Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial.

Leary SM, Miller DH, Stevenson VL, Brex PA, Chard DT, Thompson AJ.

Neurology. 2003 Jan 14;60(1):44-51.

PMID:
12525716
2.
3.
4.

[Subcutaneous interferon-beta-1a in the treatment of multiple sclerosis].

Fertl E, Krichmayr M.

Wien Med Wochenschr. 2008;158(3-4):98-109. doi: 10.1007/s10354-008-0510-6. Review. German.

PMID:
18330526
5.

Interferon beta 1a for secondary progressive multiple sclerosis.

Hughes RA.

J Neurol Sci. 2003 Feb 15;206(2):199-202. Review.

PMID:
12559511
6.

Intramuscular interferon-beta-1a: in patients at high risk of developing clinically definite multiple sclerosis.

Siddiqui MA, Wellington K.

CNS Drugs. 2005;19(1):55-61; discussion 63-4. Review.

PMID:
15651905
7.

PRISMS: the story of a pivotal clinical trial series in multiple sclerosis.

Cohen BA, Rivera VM.

Curr Med Res Opin. 2010 Apr;26(4):827-38. doi: 10.1185/03007991003604018. Review. Erratum in: Curr Med Res Opin. 2010 Aug;26(8):1826. Dosage error in article text.

PMID:
20121658
8.

Overview of London trial of intramuscular interferon-beta Ia in primary-progressive multiple sclerosis.

Miller DH, Leary SM, Thompson AJ.

Mult Scler. 2004 Jun;10 Suppl 1:S56-7. Review.

PMID:
15218810
9.

Dose and frequency of interferon treatment matter--INCOMIN and OPTIMS.

Durelli L.

J Neurol. 2003 Dec;250 Suppl 4:IV9-IV14. Review.

PMID:
14712396
10.

What is new in the treatment of multiple sclerosis?

Weinstock-Guttman B, Jacobs LD.

Drugs. 2000 Mar;59(3):401-10. Review.

PMID:
10776827
11.

Interferon β for secondary progressive multiple sclerosis: a systematic review.

La Mantia L, Vacchi L, Rovaris M, Di Pietrantonj C, Ebers G, Fredrikson S, Filippini G.

J Neurol Neurosurg Psychiatry. 2013 Apr;84(4):420-6. doi: 10.1136/jnnp-2012-303291. Epub 2012 Sep 5. Review.

PMID:
22952326
Items per page

Supplemental Content

Write to the Help Desk